INTRODUCTION:
Increasing evidence suggests that oxidative stress may play a key role in joint destruction due to rheumatoid arthritis (RA) (1) . Recent studies revealed that oxidative stress leads for example to an increase of catabolic growth factors like vascular endothelial growth factor (VEGF) (2) . Several studies could show that Nrf2 is participated in the pathogenesis of different diseases like preeclampia (3) . The aim of this study was to elucidate the role of nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor that maintains the cellular defence against oxidative stress, in RA and in antibody induced arthritis (AIA). METHODS: Activation status of Nrf2 was assessed in synovial tissue from RA-patients using immunohistochemistry. Antibody induced arthritis (AIA) was induced in Nrf2-knockout and wild-type control mice. The severity of cartilage destruction was evaluated via an arthritis score. The extent of oxidative stress, the activation state of Nrf2, and the expression level of Nrf2-target genes were analyzed via immunhistological staining. In addition, we used a Xenogen imaging system to measure Nrf2-activity in an ARE-luciferase transgenic mouse during AIA. RESULTS: Nrf2 was activated both in joints of arthritic mice and of RA patients. Nrf2-knockout mice show more severe cartilage injuries and more oxidative damage, and the expression of Nrf2-target genes were enhanced in Nrf2 wild type but not in knockout mice during AIA. Both VEGF-A mRNA and protein expression was upregulated in Nrf2-knockout mice during AIA. An unexpected finding was the number of spontaneously-fractured bones in the AIA-treated Nrf2-knockout mice. 
DISCUSSION:
These results provide strong evidence that oxidative stress is significantly involved in the cartilage degradation in experimental arthritis and indicate that the presence of a functional Nrf2 gene is a major requirement for limiting cartilage destruction.
